Chris Bindon

Chris Bindon is an accomplished professional in the pharmaceutical and biotechnology sectors, currently serving as Chief Operating Officer at NexaBiome, previously known as Fixed Phage Ltd, since March 2021. In this role, Chris provides strategic leadership across various business functions, including manufacturing, quality assurance, and process improvement, while driving the global commercialization of proprietary platforms for antibacterial therapies. Prior experience includes positions at GSK, such as Production Manager, where Chris led continuous improvement initiatives and managed production processes for Penicillin G Fermentation. Additionally, Chris held roles at Reckitt Benckiser as an R&D Senior Associate and at GSK as Product Manager and Analytical Project Leader. Chris holds an Oxford Executive Finance Programme certificate and a B.Sc. in Chemical and Pharmaceutical Sciences from the University of Sunderland, along with a NEBOSH National General Certificate in Health and Safety Management.